Skip to content

Latest edition: Sunday, November 8, 2026, 7:12 pm

General information, not personal advice

Carnet de Séance

Les sociétés cotées, chaque jour au plus fort de la séance

Ratings over the last 30 days: 0 positive, 1 neutral, 0 negative

TEP.PA

Teleperformance lowers its 2026 revenue growth forecast

On 5 November 2026, Teleperformance (TP) revised down its revenue growth forecast for 2026. The group cited weakness in its trust and safety activities.

By Yvan T., published

Illustration. Photo: lukasbieri / Pixabay

The facts

According to Boursorama, Teleperformance announced on 5 November 2026 (article published at 18:12) a downward revision of its forecasts for 2026. Zonebourse Suisse, in an article published at 22:20 the same day, specified that the revision concerned revenue growth and was explained by weakness in trust and safety activities.

According to Investir Les Echos, TP was among the SBF 120 stocks to watch on Friday 6 November 2026, alongside Euronext, Genfit, Kering and Vicat.

The available excerpts give neither the new growth range, nor the old one, nor the weight of the affected business in the group’s sales. Nor do they say how the share price reacted on the stock market.

Our take

Personal view: the revision stems from a specific segment, not from a general decline in demand. That is a fairly reassuring point, but the sources do not allow it to be verified. Without the size of the cut or the weight of this segment, it is impossible to say whether the correction is minor or structural.

The market was due to react on 6 November, which probably explains why TP is mentioned among the stocks to watch. That reaction will depend on the detailed figures, which I do not have. I therefore prefer not to take a position and not to put forward a target price, for lack of figures (revised forecasts, margins, valuation) on which to build a defensible method.

Risks to watch

The information available is limited to article headlines, with no figures on the revision. A larger-than-expected cut, or a spread of the weakness to other activities, would weigh on the share price. Conversely, a revision judged to be limited could be taken in stride, but nothing in the sources allows this to be confirmed.

Sources

  1. Teleperformance abaisse ses prévisions pour 2026 (Boursorama, 05/11/2026 18:12)
  2. TP abaisse ses prévisions de croissance du chiffre d’affaires pour 2026 en raison de la faiblesse de ses activités de confiance et de sécurité (Zonebourse Suisse, 05/11/2026 22:20)
  3. SBF 120 - Les actions à suivre vendredi: Euronext, Genfit, Kering, TP, Vicat (Investir Les Echos, 05/11/2026 19:05)

Information from these sources is summarised and rewritten. It has not been independently verified beyond cross-checking between sources; where the reliability of a piece of information is in doubt, the article says so.

Transparency

  • Author
    To be completed, Founder and author of the site, private investor.
  • Conflicts of interest
    On the publication date, holds no position in Teleperformance. The site receives no payment from the companies it covers. The author refrains from any transaction in a stock covered 24 hours before and 48 hours after publication.
  • Method
    Compilation of public information dated November 5, 2026 (sources listed above). The facts reported are kept separate from the analysis, which expresses the author's view. Full methodology.
  • Artificial intelligence
    Text written with an artificial intelligence tool from the sources cited and published automatically, without prior human review.
  • History

General information, not personalised investment advice: this article does not take your situation into account. Investing in shares carries a risk of capital loss. Past performance is not a reliable indicator of future performance. Read the full risk warning.